About CorePharma
CorePharma is a Healthcare company based in Middlesex (United States) founded in 1998, and was acquired by Impax Laboratories in March 2015. Generic pharmaceuticals are developed, manufactured, and sold by CorePharma. CorePharma offers products and services including Pharmaceutical Drugs and Quality Services. Its focus areas include Traditional Pharmaceuticals, Generics and Diversified. Its legal entity is CorePharma Inc.
Company details
CorePharma was founded in 1998 and focuses on the generic pharmaceuticals sector. Generic prescription drugs are developed, manufactured, and distributed from FDA-registered facilities in New Jersey, United States. Operations center in Middlesex. A majority stake was acquired by private equity firm Roundtable Healthcare in 2005. Products offered include Cyproheptadine, Dextroamphetamine, Glyburide, Metaxalone, and similar generics.
- Headquarters Middlesex, United States
- Stage Acquired
- SectorsHealthcare
- Website corepharma.com
- Social LinkedIn
- Acquired by Impax Laboratories (Mar 2015)
- Legal Name Corepharma Inc
- Latest Funding Round$13K (USD), Unspecified
Oct 2013
- Investors
- Acquired byImpax Laboratories
(Mar 2015)
Products & Services of CorePharma
CorePharma offers a comprehensive portfolio of products and services, including Pharmaceutical Drugs and Quality Services.
Drugs are manufactured and distributed for medical applications, with quality processes being emphasized
Quality assurance services are provided for pharmaceutical operations, supporting industry standards
Funding Insights of CorePharma
- Total Rounds 1
- Last Round Unspecified — $13,000
- First Round $13,000
(Oct 2013)
All 1 funding rounds of CorePharma with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct 2013 | $13,000 | Unspecified | – | – | – |
1 investors in total: 1 institutional.
Investors in CorePharma
CorePharma has secured backing from 1 investor. Prominent investors backing the company include Impax Laboratories.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Generic versions of brand-name medications are developed and manufactured. | 1999 | impaxlabs.com | Hayward, United States |
Investor details for CorePharma
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of CorePharma
14 people are tracked at CorePharma (4 in leadership, 10 in team).
| Name | Role | Group |
|---|---|---|
Arpit Patel | Chief Executive Officer & Founder | Leadership |
Rajendra Nagamalla | Vice President, Research & Development | Leadership |
Chintan Joshi | VP Operations & Supply Chain | Leadership |
Evan Rafanello | Vice President Of Business Development | Leadership |
Nitun Kharawla | Lead Technician (level Iv) | Team |
Emmanuel Osei-Poku | Chemist | Team |
Hinali Patel | QC Chemist I | Team |
Karan Patel | Supply Chain Specialist | Team |
William Annoh | Operations | Team |
Savan Rk Patel | Formulation Scientist | Team |
Prakash Kulkarni | CSO | Team |
Jeff Jacobus | Security | Team |
Laurent Conserve | Production Tech 3 | Team |
Michael Jesionka | Manager, CSS | Team |
Complete people profiles for CorePharma
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of CorePharma
3 dated milestones of CorePharma across 17 years, from founding to its latest funding, stage changes and deals.
- Founded CorePharma is founded.
- Funding First funding round of $13K.
- Exit Acquired by Impax Laboratories.
Web traffic of CorePharma
Websites that share an audience with CorePharma (corepharma.com).
Websites whose visitors overlap most with CorePharma. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
pharmavenue.com | pharmavenue.com | 100% | #2,309,524 | – |
Top companies in Traditional Health & Nutrition
3 companies that operate in the same segment as CorePharma (Traditional Health & Nutrition) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Manufacturer of generics formulations | 2002 | Bridgewater, New Jersey, United States | USD 3.02 B | 8,300 | ||
Biosimilar therapeutics are developed for oncology and autoimmune diseases. | 2010 | Redwood City, California, United States | USD 143.62 M | USD 42.17 M | 228 | |
Ophthalmic pharmaceuticals and instruments are developed for eye care. | 1853 | Bridgewater, New Jersey, United States | USD 5.1 B | 13,500 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about CorePharma
CorePharma was founded in 1998 and raised its 1st funding round 15 years after it was founded.
CorePharma is headquartered in Middlesex, United States.
CorePharma was founded in 1998 and focuses on the generic pharmaceuticals sector. Generic prescription drugs are developed, manufactured, and distributed from FDA-registered facilities in New Jersey, United States. Operations center in Middlesex. A majority stake was acquired by private equity firm Roundtable Healthcare in 2005. Products offered include Cyproheptadine, Dextroamphetamine, Glyburide, Metaxalone, and similar generics.
CorePharma offers Pharmaceutical Drugs and Quality Services.
CorePharma has 1 investor. Key investors include Impax Laboratories.
CorePharma operates through Corepharma Inc.
Yes. CorePharma was acquired by Impax Laboratories in March 2015.